Retrovir Syrup
by GlaxoSmithKline
Retrovir Syrup is supplied by GlaxoSmithKline under product code RETROVIR SYRUP 50 MG/5 ML, RETROVIR/AZT ORAL SOLUTION 10 MG/ML, RETROVIR ORAL SOLUTION, RETROVIR ORAL SUSPENSION, RETROVIR S SYRUP, RETROVIR SOLUCAO ORAL, RETROVIR SOLUCION ORAL, RETROVIR SOLUTION, RETROVIR SURUP, RETROVIR SYROP, ZIDOVUDINE, FORMULATED PRODUCT. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.
This SDS was last revised on 24 May 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.
- Language
- English
- Regulation
- GHS/CLP
- Revision Date
- 24 May 2018
- Signal Word
- WARNING
- Product Code
- RETROVIR SYRUP 50 MG/5 ML, RETROVIR/AZT ORAL SOLUTION 10 MG/ML, RETROVIR ORAL SOLUTION, RETROVIR ORAL SUSPENSION, RETROVIR S SYRUP, RETROVIR SOLUCAO ORAL, RETROVIR SOLUCION ORAL, RETROVIR SOLUTION, RETROVIR SURUP, RETROVIR SYROP, ZIDOVUDINE, FORMULATED PRODUCT
- CAS Number
- 56-81-5,30516-87-1,77-92-9,532-32-1
Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.
- +548+EEC
- See full Safety Data Sheet for the hazard statement wording.
Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.
Need to download the Chemical Risk Assessment? The full CRA PDF includes all hazard classifications, regulatory statements and recommended controls.